A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations

Trial Profile

A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2016

At a glance

  • Drugs Betrixaban (Primary)
  • Indications Venous thromboembolism
  • Focus Pharmacokinetics
  • Sponsors Portola Pharmaceuticals
  • Most Recent Events

    • 06 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 06 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top